The Prevalence of COPD in Individuals with Acute Coronary Syndrome: A Spirometry-Based Screening Study

References

• Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: Global burden of disease study. Lancet 1997; 349:1498–1504.
   PubMed Web of Science ®Google Scholar
• Soriano JB, Zielinski J, Price D. Screening for and early detection of chronic obstructive pulmonary disease. Lancet 2009; 374:721–732.
   PubMed Web of Science ®Google Scholar
• Finkelstein J, Cha E, Scharf SM. Chronic obstructive pulmonary disease as an independent risk factor for cardiovascular morbidity. Int J Chron Obstruct Pulmon Dis 2009; 4:337–349.
   PubMedGoogle Scholar
• Feary JR, Rodrigues LC, Smith CJ, et al. Prevalence of major co-morbidities in subjects with COPD and incidence of myocardial infarction and stroke: a comprehensive analysis using data from primary care. Thorax 2010; 65:956–962.
   PubMed Web of Science ®Google Scholar
• Sin DD, Man SFP. Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease. Circulation 2003; 107: 1514–1519.
   PubMed Web of Science ®Google Scholar
• Agustí A, Edwards LD, Rennard SI, et al. Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotype. PLoS One 2012;7:e374–383.
   Web of Science ®Google Scholar
• Mills NL, Miller JJ, Anand A, et al. Increased arterial stiffness in patients with chronic obstructive pulmonary disease: a mechanism for increased cardiovascular risk. Thorax 2008; 63:306–111.
   PubMed Web of Science ®Google Scholar
• Topsakal R, Kalay N, Ozdogru I, et al. Effects of chronic obstructive pulmonary disease on coronary atherosclerosis. Heart Vessels 2009; 24:164–168.
   PubMed Web of Science ®Google Scholar
• Lahousse L, van den Bouwhuijsen QJA, Loth DW, et al. Chronic obstructive pulmonary disease and lipid core carotid artery plaques in the elderly: the Rotterdam study. Am J Respir Crit Care Med 2013: 187:58–64.
   PubMed Web of Science ®Google Scholar
• Iwamoto H, Yokoyama A, Kitahara Y, et al. Airflow limitation in smokers is associated with subclinical atherosclerosis. Am J Respir Crit Care Med 2009; 179(1):35–40.
   PubMed Web of Science ®Google Scholar
• Behar S, Panosh A, Reicher-Reiss H, et al. Prevalence and prognosis of chronic obstructive pulmonary disease among 5,839 consecutive patients with acute myocardial infarction. sprint study group. Am J Med 1992; 93:637–641.
   PubMed Web of Science ®Google Scholar
• Hadi HA, Zubaid M, Al Mahmeed W, et al. Prevalence and prognosis of chronic obstructive pulmonary disease among 8167 Middle Eastern patients with acute coronary syndrome. Clin Cardiol 2010; 33(4):228–235.
   PubMed Web of Science ®Google Scholar
• Kjøller E, Køber L, Iversen K, et al. Importance of chronic obstructive pulmonary disease for prognosis and diagnosis of congestive heart failure in patients with acute myocardial infarction. Eur J Heart Fail 2004; 6:71–77.
   PubMed Web of Science ®Google Scholar
• Salisbury AC, Reid KJ, Spertus JA. Impact of chronic obstructive pulmonary disease on post-myocardial infarction outcomes. Am J Cardiol 2007; 99:636–641.
   PubMed Web of Science ®Google Scholar
• Hawkins NM, Huang Z, Pieper KS, et al. Chronic obstructive pulmonary disease is an independent predictor of death but not atherosclerotic events in patients with myocardial infarction: analysis of the valsartan in acute myocardial infarction trial (valiant). Eur J Heart Fail 2009; 1:292–298.
   Web of Science ®Google Scholar
• Bursi F, Vassallo R, Weston SA, et al. Chronic obstructive pulmonary disease after myocardial infarction in the community. Am Heart J 2010; 160:95–101.
   PubMed Web of Science ®Google Scholar
• Campo G, Guastaroba P, Marzocchi A, et al. Impact of COPD on long-term outcome after ST-segment elevation myocardial infarction receiving primary percutaneous coronary intervention. Chest 2013; 144(3):750–757.
   PubMed Web of Science ®Google Scholar
• Wakabayashi K, Gonzalez MA, Delhaye C, et al. Impact of chronic obstructive pulmonary disease on acute-phase outcome of myocardial infarction. Am J Cardiol. 2010; 106(3):305–309.
   PubMed Web of Science ®Google Scholar
• Danielsson P, Olafsdóttir IS, Benediktsdóttir B, et al. The prevalence of chronic obstructive pulmonary disease in Uppsala, Sweden- the burden of obstructive lung disease (BOLD) study: cross-sectional population-based study. Clin Respir J 2012; 6:120–127.
   PubMed Web of Science ®Google Scholar
• Bolton CE, Ionescu AA, Edwards PH, et al. Attaining a correct diagnosis of COPD in general practice. Respir Med. 2009; 99:493–500.
   Web of Science ®Google Scholar
• Walker PP, Mitchell P, Diamantea F, et al. Effect of primary care spirometry on the diagnosis and management of . Eur Respir J 2008; 28:945–952.
   Web of Science ®Google Scholar
• Arne M, Lisspers K, Ställberg B, et al. How often is diagnosis of COPD confirmed with spirometry? Respir Med 2010; 104:550–556.
   PubMed Web of Science ®Google Scholar
• Soriano JB, Rigo F, Guerrero D, et al. High prevalence of undiagnosed airow limitation in patients with cardiovascular disease. Chest 2010; 137:333–340.
   PubMed Web of Science ®Google Scholar
• Thygesen K, Alpert JS, White HD et al. Universal definition of myocardial infarction. Circulation 2007; 116:2634–2653
   PubMed Web of Science ®Google Scholar
• Thygesen K, Alpert JS, Jaffe AS et al. Third universal definition of myocardial infarction. Eur Heart J 2012; 33:2551–2567
   PubMed Web of Science ®Google Scholar
• Rabe KF, Hurd S, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007; 176:532–355.
   PubMed Web of Science ®Google Scholar
• Hedenström H, Malmberg P, Agarwal K. Reference values for lung function tests in females. regression equations with smoking variables. Bull Eur Physiopathol Respir 1985; 21:551–557.
   PubMedGoogle Scholar
• Hedenström H, Malmberg P, Fridriksson HV. Reference values for lung function tests in men: regression equations with smoking variables. Ups J Med Sci 1986; 91:299–310.
   PubMed Web of Science ®Google Scholar
• Salpeter S, Ormiston T, Salpeter E. Cardioselective beta-blockers for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2005 Issue 4. Art. No.: CD003566. DOI: 10.1002/14651858.CD003566.pub2.
   PubMed Web of Science ®Google Scholar
• Lindberg A, Jonsson AC, Rönmark E, et al. Prevalence of chronic obstructive pulmonary disease according to BTS, ERS, GOLD and ATS criteria in relation to doctor's diagnosis, symptoms, age, gender, and smoking habits. Respiration 2005; 72:471–479.
   PubMed Web of Science ®Google Scholar
• Wada H, Nakano Y, Nagao T, et al. Detection and prevalence of chronic obstructive pulmonary disease in a cardiovascular clinic: evaluation using a hand held FEV1/FEV6 meter and questionnaire. Respirology 2010; 15:1252–1258.
   PubMed Web of Science ®Google Scholar
• White WB, Cooke GE, Kowey PR, et al. Cardiovascular Safety in Patients Receiving Roflumilast for the Treatment of COPD. Chest 2013; 144(3):758–765.
   PubMed Web of Science ®Google Scholar
• Malmberg K, Rydén L, Efendic S, et al. Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMIstudy): effects on mortality at 1 year. J Am Coll Cardiol 1995; 26(1):57–65.
   PubMed Web of Science ®Google Scholar
• Mohamed Hoesein FA, Zanen P, Lammers JW. Lower limit of normal or FEV1/FVC < 0.70 in diagnosing COPD: an evidence-based review. Respir Med 2011; 105(6):907–915.
   PubMed Web of Science ®Google Scholar
• Eriksson B, Lindberg A, Müllerova H, et al. Association of heart diseases with COPD and restrictive lung function–results from a population survey. Respir Med 2013; 107(1):98–106.
   PubMed Web of Science ®Google Scholar
• Johnston AK, Mannino DM, Hagan GW, et al. Relationship between lung function impairment and incidence or recurrence of cardiovascular events in a middle-aged cohort. Thorax 2008; 63(7):599–605.
   PubMed Web of Science ®Google Scholar
• Guerra S, Sherrill DL, Venker C, et al. Morbidity and mortality associated with the restrictive spirometric pattern: a longitudinal study. Thorax 2010; 65(6):499–504.
   PubMed Web of Science ®Google Scholar